The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized phase II trial comparing the efficacy of standard-dose with high-dose twice-daily thoracic radiotherapy (TRT) in limited disease small-cell lung cancer (LD SCLC).
 
Bjorn Henning Gronberg
Employment - Lilly (I)
Stock and Other Ownership Interests - Lilly (I)
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; MSD; Novartis; Pfizer; Roche
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Takeda
Research Funding - AstraZeneca; MSD; Roche
 
Kristin Toftaker Killingberg
Research Funding - AstraZeneca (Inst); MSD (Inst); Roche (Inst)
 
Øystein Fløtten
No Relationships to Disclose
 
Maria Moksnes Bjaanæs
Consulting or Advisory Role - Novartis
 
Tesfaye Madebo
No Relationships to Disclose
 
Seppo Langer
Employment - Genmab (I)
Stock and Other Ownership Interests - Genmab (I)
Consulting or Advisory Role - Novartis; Roche
Research Funding - Abbvie
Travel, Accommodations, Expenses - Ipsen
 
Tine Schytte
Travel, Accommodations, Expenses - Elekta
 
Odd Terje Brustugun
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD Oncology; Novartis; Pfizer
Consulting or Advisory Role - Bayer Health (Inst); MSD Oncology (Inst); Roche (Inst); Takeda (Inst)
Research Funding - Abbvie (Inst); ARIAD (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
 
Jan Nyman
No Relationships to Disclose
 
Kristin Stokke
Research Funding - AstraZeneca (Inst); MSD (Inst); Roche (Inst)
 
Tarje Onsøien Halvorsen
Honoraria - MSD; Pierre Fabre
Research Funding - AstraZeneca (Inst); MSD (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; MSD